Cargando…

Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial

Detalles Bibliográficos
Autores principales: Cohen, Ricardo V., Petry, Tarissa Beatrice Zanata, Miras, Alexander Dimitri, Aboud, Cristina Mamédio, Johnson, Brett, dos Santos, Tiago Mendonça, le Roux, Carel W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740946/
https://www.ncbi.nlm.nih.gov/pubmed/34362818
http://dx.doi.org/10.2337/dc21-1192
_version_ 1784629402925006848
author Cohen, Ricardo V.
Petry, Tarissa Beatrice Zanata
Miras, Alexander Dimitri
Aboud, Cristina Mamédio
Johnson, Brett
dos Santos, Tiago Mendonça
le Roux, Carel W.
author_facet Cohen, Ricardo V.
Petry, Tarissa Beatrice Zanata
Miras, Alexander Dimitri
Aboud, Cristina Mamédio
Johnson, Brett
dos Santos, Tiago Mendonça
le Roux, Carel W.
author_sort Cohen, Ricardo V.
collection PubMed
description
format Online
Article
Text
id pubmed-8740946
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-87409462022-01-10 Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial Cohen, Ricardo V. Petry, Tarissa Beatrice Zanata Miras, Alexander Dimitri Aboud, Cristina Mamédio Johnson, Brett dos Santos, Tiago Mendonça le Roux, Carel W. Diabetes Care e-Letters – Observations American Diabetes Association 2021-10 2021-08-06 /pmc/articles/PMC8740946/ /pubmed/34362818 http://dx.doi.org/10.2337/dc21-1192 Text en © 2021 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.
spellingShingle e-Letters – Observations
Cohen, Ricardo V.
Petry, Tarissa Beatrice Zanata
Miras, Alexander Dimitri
Aboud, Cristina Mamédio
Johnson, Brett
dos Santos, Tiago Mendonça
le Roux, Carel W.
Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial
title Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial
title_full Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial
title_fullStr Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial
title_full_unstemmed Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial
title_short Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial
title_sort renoprotective effects of the combination of empagliflozin and liraglutide compared with roux-en-y gastric bypass in early-stage diabetic kidney disease: a post hoc analysis of the microvascular outcomes after metabolic surgery (moms) randomized controlled clinical trial
topic e-Letters – Observations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740946/
https://www.ncbi.nlm.nih.gov/pubmed/34362818
http://dx.doi.org/10.2337/dc21-1192
work_keys_str_mv AT cohenricardov renoprotectiveeffectsofthecombinationofempagliflozinandliraglutidecomparedwithrouxenygastricbypassinearlystagediabetickidneydiseaseaposthocanalysisofthemicrovascularoutcomesaftermetabolicsurgerymomsrandomizedcontrolledclinicaltrial
AT petrytarissabeatricezanata renoprotectiveeffectsofthecombinationofempagliflozinandliraglutidecomparedwithrouxenygastricbypassinearlystagediabetickidneydiseaseaposthocanalysisofthemicrovascularoutcomesaftermetabolicsurgerymomsrandomizedcontrolledclinicaltrial
AT mirasalexanderdimitri renoprotectiveeffectsofthecombinationofempagliflozinandliraglutidecomparedwithrouxenygastricbypassinearlystagediabetickidneydiseaseaposthocanalysisofthemicrovascularoutcomesaftermetabolicsurgerymomsrandomizedcontrolledclinicaltrial
AT aboudcristinamamedio renoprotectiveeffectsofthecombinationofempagliflozinandliraglutidecomparedwithrouxenygastricbypassinearlystagediabetickidneydiseaseaposthocanalysisofthemicrovascularoutcomesaftermetabolicsurgerymomsrandomizedcontrolledclinicaltrial
AT johnsonbrett renoprotectiveeffectsofthecombinationofempagliflozinandliraglutidecomparedwithrouxenygastricbypassinearlystagediabetickidneydiseaseaposthocanalysisofthemicrovascularoutcomesaftermetabolicsurgerymomsrandomizedcontrolledclinicaltrial
AT dossantostiagomendonca renoprotectiveeffectsofthecombinationofempagliflozinandliraglutidecomparedwithrouxenygastricbypassinearlystagediabetickidneydiseaseaposthocanalysisofthemicrovascularoutcomesaftermetabolicsurgerymomsrandomizedcontrolledclinicaltrial
AT lerouxcarelw renoprotectiveeffectsofthecombinationofempagliflozinandliraglutidecomparedwithrouxenygastricbypassinearlystagediabetickidneydiseaseaposthocanalysisofthemicrovascularoutcomesaftermetabolicsurgerymomsrandomizedcontrolledclinicaltrial